Insurance AR Recovery
Insurance AR recovery across Medicare, Medicaid, and commercial payers. Denied claims worked by root cause, not by age alone.
Laboratory billing runs on volume: hundreds or thousands of claims per week, most of them low-dollar, each requiring lab-specific CPT, HCPCS, or PLA coding that general billers do not handle. At lab margins, a single coding error on a routine panel costs pennies to make and weeks to fix. MedKaira delivers dedicated lab billing with 48-hour denial turnaround and active PAMA compliance.
PAMA · CLIA · HIPAA Compliant
Operational Difference
Physician practices process 20 to 60 claims per day at $150 to $500 each. A denied claim justifies the $25 to $57 in rework cost.
Labs process hundreds of claims daily at $10 to $50 each. A denied $15 CBC panel is not worth reworking, so it gets written off. Multiply that across a month and the leak is material.
The coding is structurally different too. Labs work with CPT codes (80047 through 89398), HCPCS, and Proprietary Laboratory Analyses (PLA) codes that update quarterly through the AMA. The AMA estimates that the majority of laboratory claims ship with incorrect codes. Factor in CLIA tier requirements, payer-specific medical necessity rules, Medically Unlikely Edit (MUE) caps, and the technical-versus-professional component split, and general billing expertise falls short.
Regulatory Impact
PAMA has been cutting Medicare lab payments since 2018 according to ASCP and NILA, and the reductions hit routine panels hardest. The Consolidated Appropriations Act of 2026 delayed the next round through December 31, 2026, but cuts resume in 2027 based on private payer data labs are reporting to CMS during the May 1 through July 31, 2026, window.
We help labs navigate PAMA data reporting: identifying whether your lab meets the applicable laboratory threshold, collecting the required HCPCS codes, private payer rates, and test volumes, and submitting cleanly within the CMS deadline.
Scope of Services
We are a lab billing partner built for volume and precision. Our laboratory billing services cover the full revenue cycle for clinical labs, hospital outreach, reference labs, molecular diagnostics, toxicology, and pathology practices. Coding, claim submission, denial management, PAMA compliance, and CLFS reporting—handled by a team that does lab billing exclusively.
Coding is where most lab revenue is won or lost. Clinical laboratory billing requires tracking quarterly PLA code updates, monitoring LCD and NCD changes for medical necessity determinations, and verifying MolDX Z-code registration for molecular assays where required by Medicare Administrative Contractors and commercial payers. When a test does not have an established code, we identify the correct unlisted code and documentation path.
Insurance AR recovery across Medicare, Medicaid, and commercial payers. Denied claims worked by root cause, not by age alone.
Lab-specific CPT codes (80047-89398), HCPCS Level II, and quarterly PLA updates applied by coders who work lab claims exclusively.
We identify whether your lab meets the applicable threshold, collect required data, and submit within the CMS reporting window.
Root-cause analysis and resubmission within 48 hours. Denial patterns tracked across your full claim volume to prevent recurrence.
Z-code registration through the MolDX program for molecular assays. Prior authorization managed for genetic panels before testing.
Payer enrollment and re-credentialing kept current across all lab locations. Lapsed enrollments flagged before they hold payments.
Specialized Focus
High volumes across routine panels like CBC, BMP, CMP, and lipids. We manage each claim individually, not in blind batches, so coding and eligibility errors are caught pre-submission.
The 14-day rule bundles lab tests ordered within 14 days of outpatient discharge into the hospital encounter. We flag these before submission to prevent bundling denials.
PLA codes for proprietary tests update quarterly, and advanced molecular tests require manual rate defense. We manage MolDX Z-code registration and prior auth for genetic panels.
Payer scrutiny around medical necessity is intense for confirmatory testing beyond presumptive screens. We verify each claim stays within MUE unit caps and documents clinical rationale.
Surgical pathology levels (88300-88309), immunohistochemistry (88342-88346), and cytopathology require complexity-based coding. We manage the TC and Modifier 26 split on every interpretation.
Send-out tests routed through reference labs need correct billing entity assignment and specimen-specific CPT matching. We track which lab performed the test and bill under the correct provider.
Interoperability
You keep your LIS and EHR. We work inside your existing setup with integrations configured during onboarding with zero disruption to clinical workflows.
Fast Deployment
We analyze a sample of your recent lab claims, denial codes, and PAMA exposure to identify instant leaks.
We execute a comprehensive HIPAA Business Associate Agreement and define custom claim scrub rules.
We configure EDI connectivity, clearinghouse routing tables, and test batch transmission.
Daily claim scrub begins, 48-hour denial appeals launch, and weekly executive cash reconciliation delivers.
Got Questions?
Direct answers for labs, pathology practices, and diagnostic centers evaluating an expert revenue cycle partner.
Labs process high volumes of low-dollar claims where the cost of reworking a denial often exceeds the claim value. Lab coding involves CPT, HCPCS, and PLA codes that update quarterly, payer-specific medical necessity rules, CLIA tier requirements, MUE unit caps, and technical-versus-professional component splits that physician billing does not deal with.
PAMA is the Protecting Access to Medicare Act. It restructured Medicare lab payments based on private payer rate data. Since 2018, PAMA has cut over $4 billion in Medicare lab payments. The next round of 15% annual reductions begins in 2027 based on data labs are reporting to CMS during the May through July 2026 window.
Independent clinical labs, hospital outreach programs, reference labs, molecular diagnostics and genetic testing labs, toxicology labs, and pathology practices. Each lab type has distinct coding, compliance, payer, and regulatory requirements that we manage as part of the engagement.
Pathology billing uses dual coding systems: anatomic pathology (CPT 88000 through 88399) and clinical pathology (80047 through 85999). We code surgical pathology levels, immunohistochemistry, and cytopathology by complexity, and manage the technical component (TC) and professional component (modifier 26) split on every interpretation to prevent component denials.
We analyze each denial by root cause, whether that is a coding error, missing modifier, eligibility gap, or medical necessity rejection. We correct the issue and resubmit or appeal within 48 hours. We also track denial patterns across your claim volume to fix recurring problems at the workflow level, not one claim at a time.
Yes. We help labs determine whether they meet the applicable laboratory threshold, collect the required HCPCS codes, private payer rates, and test volumes, and submit within the CMS reporting window.
CPT codes for standard lab and diagnostic tests, HCPCS for supplies and certain services, and PLA codes for proprietary tests. PLA codes update quarterly through the AMA. For molecular assays, we also manage MolDX Z-code registration where required by Medicare Administrative Contractors and commercial payers.
Request a free revenue assessment. We review your current denial rate, coding accuracy, payer mix, and PAMA exposure, then deliver a written report with your findings, estimated recoverable revenue, and specific recommendations for your lab type. No obligation, no upfront cost, and you keep the report.
Ready When You Are
The free revenue assessment covers your denial rate by root cause, coding accuracy against current CPT and PLA code sets, PAMA reporting status, and estimated recoverable revenue. You keep the findings whether or not you work with us.
Confidential · BAA Signed Prior to Analysis · All 50 States